Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Runway Growth Finance Third Quarter 2024 Earnings Conference Call.
Los Angeles-based marketing agency Runway Influence has recently expanded its footprint in the content and influencer ...
One-legged trousers stepped up as the unlikely runway trend that no one could have ... with one leg shrouded in fabric and the other exposed, as part of a collection of workplace womenswear ...
Cellebrite has a significant opportunity to expand its business beyond digital forensics. Click here for our investment ...
In 2018 when Harvey Weinstein was exposed as a sexual predator, The Weinstein Company went under and the rights to Project Runway went up for grabs. Later that year at the NBCUniversal Upfronts ...
On Tuesday, Oct. 15, the Italian-French model and singer, 56, rocked the runway in a sexy ... event in awe as she strutted in a corset with exposed, sparkling boning and matching, barely-there ...
we believe Runway will deliver more comprehensive financing solutions for a wider range of companies. Moving forward, we expect that our investors will benefit from increased exposure and access to a ...
Leave it to Kylie Jenner to make magic out of her first Paris Fashion Week runway appearance. The reality star and entrepreneur’s closure of Coperni’s spring 2025 fashion show at Disneyland ...
[Powell] has exposed them to a lot of something,” Rogers said ... It was Robinson’s first time walking the runway. “I’m so happy for [Robinson]. It’s something that she likes to do, so I’m happy,” ...
Project Runway is gearing up for season 21. After months of fans wondering if season 20 would be its last, it was announced in October 2024 that the long-running fashion design competition will ...
The markets JT sells in boast relatively low cigarette prices, giving it a much longer runway for future price increases before consumers push back than its peers. JT’s international exposure ...
Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...